• Publications
  • Influence
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia.
BACKGROUND & AIMS Intrasphincteric injection of botulinum toxin has been suggested as an alternative treatment modality in esophageal achalasia. A controlled trial comparing botulinum toxin, placebo,Expand
  • 151
  • 4
Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group
OBJECTIVES Little is known about factors influencing the spread of blepharospasm to other body parts. An investigation was carried out to deterrmine whether demographic features (sex, age atExpand
  • 54
  • 4
  • PDF
Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses
Aim  The aim of the present study was to evaluate the efficacy and safety of three doses of botulinum toxin type B (BoNT‐B) in reducing persistent sialorrhoea in children with cerebral palsy (CP).
  • 33
  • 4
  • PDF
Long‐term functional outcome and health status of patients with critical illness polyneuromyopathy
Intiso D, Amoruso L, Zarrelli M, Pazienza L, Basciani M, Grimaldi G, Iarossi A, Di Rienzo F. Long‐term functional outcome and health status of patients with critical illness polyneuromyopathy.
ActaExpand
  • 50
  • 3
Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans.
VEPs were recorded with three different spatial frequencies of stimulation in patients affected by idiopathic Parkinsonism and by Parkinsonian syndromes. The detection of VEP abnormalities inExpand
  • 102
  • 2
  • PDF
Botulinum toxin type-A and plaster cast treatment in children with upper brachial plexus palsy
Summary BACKGROUND AND PURPOSE: Electrical stimulation, physical therapy and occupational therapy remain the main treatment for children with upper brachial plexus palsy (UBPP), when surgery has beenExpand
  • 37
  • 2
Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study
Primary palmar hyperhidrosis is a distressing and disabling condition that can produce social, psychological and occupational problems. Although the use of botulinum toxin type A (BoNT-A) has beenExpand
  • 8
  • 2
Maps of somatosensory evoked potentials (SEPs) to mechanical (tapping) stimuli: comparison with P14, N20, P22, N30 of electrically elicited SEPs.
Bit mapped color imaging of SEPs was recorded from 19 derivations in 11 healthy volunteers after electrical stimulation of the median nerve at the wrist, index finger digital nerve stimulation, andExpand
  • 19
  • 1
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke
Botulinum toxin type A (BTX-A) represents the gold standard therapy for focal spasticity after stroke, with low prevalence of complications, reversibility, and efficacy in reducing spasticExpand
  • 28
  • 1
Botulinum toxin use in neuro-rehabilitation to treat obstetrical plexus palsy and sialorrhea following neurological diseases: a review.
In neuro-rehabilitation, botulinum toxin (BTX) as adjunct to other interventions can result in a useful therapeutic tool treating disabled people. Other than spasticity, numerous motor and non motorExpand
  • 14
  • 1
  • PDF